Alpelisib

Basic Information

Item Value
DrugBank ID DB12015
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 pulmonary hypertension KG + DL
2 migraine with or without aura, susceptibility to KG + DL
3 migraine disorder KG + DL
4 kyphoscoliotic heart disease KG + DL
5 rheumatoid arthritis KG + DL
6 leprosy KG + DL
7 migraine with brainstem aura KG + DL
8 thrombotic disease KG + DL
9 amyotrophic lateral sclerosis KG + DL
10 multiple endocrine neoplasia KG + DL
11 brachydactyly-syndactyly syndrome KG + DL
12 amyotrohpic lateral sclerosis type 22 KG + DL
13 nephrogenic syndrome of inappropriate antidiuresis KG + DL
14 Mills syndrome KG + DL
15 amyotrophic lateral sclerosis, susceptibility to KG + DL
16 female breast carcinoma KG + DL
17 coronary artery disease KG + DL
18 Prinzmetal angina KG + DL
19 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
20 axial spondylometaphyseal dysplasia KG + DL
21 homozygous familial hypercholesterolemia KG + DL
22 vein disease KG + DL
23 atrophoderma vermiculata KG + DL
24 bilateral parasagittal parieto-occipital polymicrogyria KG + DL
25 trichomegaly-retina pigmentary degeneration-dwarfism syndrome KG + DL
26 monomelic amyotrophy KG + DL
27 lethal arthrogryposis-anterior horn cell disease syndrome KG + DL
28 lower motor neuron syndrome with late-adult onset KG + DL
29 ulerythema ophryogenesis KG + DL
30 anomalous left coronary artery from the pulmonary artery KG + DL
31 angiodysplasia KG + DL
32 venous thromboembolism KG + DL
33 fibrocartilaginous embolism KG + DL
34 myocardial ischemia KG + DL
35 arteriosclerosis disorder KG + DL
36 autosomal dominant mitochondrial myopathy with exercise intolerance KG + DL
37 non-inflammatory vasculopathy KG + DL
38 cardiovascular disease KG + DL
39 cytomegalovirus infection KG + DL
40 uterine corpus leiomyoma KG + DL
41 congenital renal artery stenosis KG + DL
42 generalized atherosclerosis KG + DL
43 cerebral atherosclerosis KG + DL
44 dermatofibrosarcoma protuberans KG + DL
45 heart conduction disease KG + DL
46 cor pulmonale KG + DL
47 heart neoplasm KG + DL
48 coronary atherosclerosis KG + DL
49 thrombocytopenia KG + DL
50 cysticercosis KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.